Skip to content
10-K

Annual Report

TALON THERAPEUTICS, INC.

0001437749-13-003773

← back to feed
Filed
Apr 1, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 29, 2013 22.01M sh
Stock Issued FY 2012 · Jan 11, 2013 60K sh
Stock Issued FY 2012 · Jan 8, 2013 9.77K sh
Stock Issued FY 2012 · Jul 5, 2012 36.7K sh
Stock Issued FY 2012 · May 31, 2012 15K sh
Stock Issued FY 2012 · Jan 9, 2012 10.75K sh
Shares Diluted FY 2012 · Dec 31, 2012 21.93M sh
Shares Diluted FY 2012 · Dec 31, 2011 21.56M sh
Capex FY 2012 · Dec 31, 2012 $13.55K
Capex FY 2012 · Dec 31, 2011 $70.34K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$20.23M
Operating Cash Flow FY 2012 · Dec 31, 2011 −$21.86M
Cash And Equivalents FY 2012 · Dec 31, 2012 $2.97M
Cash And Equivalents FY 2012 · Dec 31, 2011 $1.03M
Cash And Equivalents FY 2012 · Dec 31, 2010 $4.57M
Stockholders Equity FY 2012 · Dec 31, 2012 −$87.05M
Stockholders Equity FY 2012 · Dec 31, 2011 −$59.02M
Current Liabilities FY 2012 · Dec 31, 2012 $17.83M
Current Liabilities FY 2012 · Dec 31, 2011 $4.56M
Total Liabilities FY 2012 · Dec 31, 2012 $43.22M
Total Liabilities FY 2012 · Dec 31, 2011 $30.87M
Current Assets FY 2012 · Dec 31, 2012 $3.49M
Current Assets FY 2012 · Dec 31, 2011 $1.66M
Total Assets FY 2012 · Dec 31, 2012 $4.09M
Total Assets FY 2012 · Dec 31, 2011 $2.49M
Eps Diluted FY 2012 · Dec 31, 2012 −$2.95
Eps Diluted FY 2012 · Dec 31, 2011 −$1.06
Sga Expense FY 2012 · Dec 31, 2012 $7.9M
Sga Expense FY 2012 · Dec 31, 2011 $5.12M
Rd Expense FY 2012 · Dec 31, 2012 $12.9M
Rd Expense FY 2012 · Dec 31, 2011 $13.39M
Net Income FY 2012 · Dec 31, 2012 −$43.7M
Net Income FY 2012 · Dec 31, 2011 −$18.82M
Operating Income FY 2012 · Dec 31, 2012 −$20.8M
Operating Income FY 2012 · Dec 31, 2011 −$18.51M